Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.12
72% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $18.0K | $26.0K | $26.0K | $0 | $59.0K |
| Gross profit | −$18.0K | −$26.0K | −$26.0K | $0 | −$59.0K |
| Gross margin | — | — | — | — | — |
| R&D | $414.0K | $2.2M | $1.7M | $1.4M | $1.5M |
| Operating income | −$3.1M | −$5.0M | −$5.0M | −$6.4M | −$6.4M |
| EBITDA | −$3.1M | −$5.0M | −$4.7M | −$6.0M | −$6.4M |
| Net income | −$2.3M | −$4.7M | −$3.9M | −$5.8M | −$5.7M |
| Net margin | — | — | — | — | — |
| EPS (diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $0 | $-0.01 | $-0.01–$-0.01 | 1 |
Forward consensus · source: Financial Modeling Prep
POOLBEG PHARMA PLC
No one on the platform currently holds POLBF.
No tracked institution reports a position in POLBF as of their last filing.
No one on the platform has traded POLBF yet.
| $97M |
| — |
| PBIGFParadigm Biopharmaceuticals Limited | $0.13 | -10.20% | $57M | — |
| PFGTFPacific Edge Limited | $0.17 | +0.00% | $212M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.